| References |
1. Mizobe T, Oda Y, Natsuyama T, Miyazaki M. Anesthetic management with eptazocine hydrobromide in patients receiving long-term antipsychotic medication. J Anesth. 1992 Jan;6(1):21-7. PubMed PMID: 15278579. 2. Yanaura S, Kitagawa H, Hosokawa T, Misawa M. [Effects of methanobenzazonine (2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benzazonine) derivatives on the cough reflex and respiration]. Nihon Yakurigaku Zasshi. 1982 Jul;80(1):43-50. Japanese. PubMed PMID: 7173733. 3. Koizumi T, Kakemi M, Katayama K, Ogawa M. A pharmcokinetic model for enterohepatic circulation of an analgesic l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benzazonine hydrobromide (l-ST-2121) in rats. J Pharmacobiodyn. 1981 Jul;4(7):461-8. PubMed PMID: 7299614. 4. Ogawa M, Nogami Y, Miyamura Y, Kameda S, Tsuji S, Miyamura Y, Miyamoto S, Koizumi T. [Metabolic fate of a new analgesics l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benzazonine hydrobromide (l-ST-2121). III.) Absorption, excretion and metabolism in mouse rat, rabbit, dog, monkey and man (author's transl)]. Yakugaku Zasshi. 1980 Sep;100(9):967-72. Japanese. PubMed PMID: 7218159. |
